In this issue:
Talazoparib + enzalutamide for mCRPC
Race and treatments outcomes in patients with mHSPC
EBRT for intermediate-risk prostate cancer
Hypofractionation adoption in prostate cancer radiotherapy
Transcriptomic signatures associated with recurrent prostate cancer outcomes
Early on-treatment changes in ctDNA fraction in mCRPC
Prostatectomy bed image-guided dose-escalated salvage radiotherapy
Salvage SBRT for intraprostatic tumour recurrence after EBRT
PSA density threshold for identification of clinically significant prostate cancer
Depression and suicide among men with prostate cancer
Please login below to download this issue (PDF)